Minerva Surgical, Inc. (UTRS)

Minerva Surgical Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	51.69	50.29	52.1	37.77	26.01
Revenue Growth (YoY)	3.11%	-3.47%	37.95%	45.20%	-
Cost of Revenue	23.69	23.05	21.58	18.65	14.21
Gross Profit	28.01	27.24	30.52	19.12	11.81
Selling, General & Admin	56.15	61.79	53.95	30.36	30.51
Research & Development	6.11	5.44	5.29	3.32	0.94
Operating Expenses	62.26	67.24	59.24	33.69	31.44
Operating Income	-34.26	-39.99	-28.72	-14.57	-19.64
Interest Expense	-4.4	-3.22	-11.73	-12.14	-17.58
Interest & Investment Income	0.3	0.09	0.01	0.08	0.14
Other Non Operating Income (Expenses)	-0.04	-0.07	37.67	8.41	-6.69
EBT Excluding Unusual Items	-38.4	-43.2	-2.77	-18.21	-43.77
Merger & Restructuring Charges	-	-	-	-1	-
Other Unusual Items	5	9.09	-18.69	0.82	-8.28
Pretax Income	-33.4	-34.1	-21.46	-18.4	-52.05
Income Tax Expense	0.05	0.01	0.01	-0.13	-
Net Income	-33.45	-34.11	-21.46	-18.26	-52.05
Net Income to Common	-33.45	-34.11	-21.46	-18.26	-52.05
Shares Outstanding (Basic)	6	1	0	0	0
Shares Outstanding (Diluted)	6	1	0	0	0
Shares Change (YoY)	363.35%	310.83%	623.92%	7.49%	-
EPS (Basic)	-5.38	-23.68	-61.22	-377.09	-1155.06
EPS (Diluted)	-5.38	-23.68	-61.22	-377.09	-1155.06
Free Cash Flow	-38.79	-35.64	-22.96	-12.69	-20.02
Free Cash Flow Per Share	-6.23	-24.74	-65.49	-262.10	-444.19
Gross Margin	54.18%	54.17%	58.58%	50.63%	45.38%
Operating Margin	-66.27%	-79.52%	-55.12%	-38.56%	-75.49%
Profit Margin	-64.71%	-67.83%	-41.20%	-48.36%	-200.08%
Free Cash Flow Margin	-75.03%	-70.86%	-44.07%	-33.61%	-76.94%
EBITDA	-25.56	-29.19	-18.1	-7.49	-17.96
EBITDA Margin	-49.45%	-58.03%	-34.73%	-19.83%	-69.05%
D&A For EBITDA	8.7	10.81	10.62	7.08	1.68
EBIT	-34.26	-39.99	-28.72	-14.57	-19.64
EBIT Margin	-66.27%	-79.52%	-55.12%	-38.56%	-75.49%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.